317 related articles for article (PubMed ID: 12213582)
1. Nuclear factor-kappa B and cancer: its role in prevention and therapy.
Bharti AC; Aggarwal BB
Biochem Pharmacol; 2002 Sep; 64(5-6):883-8. PubMed ID: 12213582
[TBL] [Abstract][Full Text] [Related]
2. Chemopreventive agents induce suppression of nuclear factor-kappaB leading to chemosensitization.
Bharti AC; Aggarwal BB
Ann N Y Acad Sci; 2002 Nov; 973():392-5. PubMed ID: 12485899
[TBL] [Abstract][Full Text] [Related]
3. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.
Shishodia S; Majumdar S; Banerjee S; Aggarwal BB
Cancer Res; 2003 Aug; 63(15):4375-83. PubMed ID: 12907607
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer.
Shishodia S; Aggarwal BB
Cancer Treat Res; 2004; 119():139-73. PubMed ID: 15164877
[No Abstract] [Full Text] [Related]
5. Sesamin manifests chemopreventive effects through the suppression of NF-kappa B-regulated cell survival, proliferation, invasion, and angiogenic gene products.
Harikumar KB; Sung B; Tharakan ST; Pandey MK; Joy B; Guha S; Krishnan S; Aggarwal BB
Mol Cancer Res; 2010 May; 8(5):751-61. PubMed ID: 20460401
[TBL] [Abstract][Full Text] [Related]
6. Nuclear factor-kappaB: the enemy within.
Aggarwal BB
Cancer Cell; 2004 Sep; 6(3):203-8. PubMed ID: 15380510
[TBL] [Abstract][Full Text] [Related]
7. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.
Hsu TC; Nair R; Tulsian P; Camalier CE; Hegamyer GA; Young MR; Colburn NH
Cancer Res; 2001 May; 61(10):4160-8. PubMed ID: 11358840
[TBL] [Abstract][Full Text] [Related]
8. Morin (3,5,7,2',4'-Pentahydroxyflavone) abolishes nuclear factor-kappaB activation induced by various carcinogens and inflammatory stimuli, leading to suppression of nuclear factor-kappaB-regulated gene expression and up-regulation of apoptosis.
Manna SK; Aggarwal RS; Sethi G; Aggarwal BB; Ramesh GT
Clin Cancer Res; 2007 Apr; 13(7):2290-7. PubMed ID: 17404114
[TBL] [Abstract][Full Text] [Related]
9. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
Pandey MK; Sung B; Kunnumakkara AB; Sethi G; Chaturvedi MM; Aggarwal BB
Cancer Res; 2008 Jul; 68(13):5370-9. PubMed ID: 18593939
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling.
Aggarwal S; Takada Y; Singh S; Myers JN; Aggarwal BB
Int J Cancer; 2004 Sep; 111(5):679-92. PubMed ID: 15252836
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel blocker of I kappa B alpha kinase that enhances cellular apoptosis and inhibits cellular invasion through suppression of NF-kappa B-regulated gene products.
Ichikawa H; Takada Y; Murakami A; Aggarwal BB
J Immunol; 2005 Jun; 174(11):7383-92. PubMed ID: 15905586
[TBL] [Abstract][Full Text] [Related]
12. Deguelin, an Akt inhibitor, suppresses IkappaBalpha kinase activation leading to suppression of NF-kappaB-regulated gene expression, potentiation of apoptosis, and inhibition of cellular invasion.
Nair AS; Shishodia S; Ahn KS; Kunnumakkara AB; Sethi G; Aggarwal BB
J Immunol; 2006 Oct; 177(8):5612-22. PubMed ID: 17015749
[TBL] [Abstract][Full Text] [Related]
13. NF-kappaB and cancer: how intimate is this relationship.
Prasad S; Ravindran J; Aggarwal BB
Mol Cell Biochem; 2010 Mar; 336(1-2):25-37. PubMed ID: 19823771
[TBL] [Abstract][Full Text] [Related]
14. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products.
Ahn KS; Sethi G; Aggarwal BB
Mol Pharmacol; 2007 Jan; 71(1):209-19. PubMed ID: 17028156
[TBL] [Abstract][Full Text] [Related]
15. Zerumbone abolishes NF-kappaB and IkappaBalpha kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion.
Takada Y; Murakami A; Aggarwal BB
Oncogene; 2005 Oct; 24(46):6957-69. PubMed ID: 16007145
[TBL] [Abstract][Full Text] [Related]
16. NF-κB in cancer therapy.
Li F; Zhang J; Arfuso F; Chinnathambi A; Zayed ME; Alharbi SA; Kumar AP; Ahn KS; Sethi G
Arch Toxicol; 2015 May; 89(5):711-31. PubMed ID: 25690730
[TBL] [Abstract][Full Text] [Related]
17. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
[TBL] [Abstract][Full Text] [Related]
18. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression.
Takada Y; Ichikawa H; Badmaev V; Aggarwal BB
J Immunol; 2006 Mar; 176(5):3127-40. PubMed ID: 16493072
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting NF-κB activation by small molecules as a therapeutic strategy.
Gupta SC; Sundaram C; Reuter S; Aggarwal BB
Biochim Biophys Acta; 2010; 1799(10-12):775-87. PubMed ID: 20493977
[TBL] [Abstract][Full Text] [Related]
20. β-Caryophyllene oxide potentiates TNFα-induced apoptosis and inhibits invasion through down-modulation of NF-κB-regulated gene products.
Kim C; Cho SK; Kim KD; Nam D; Chung WS; Jang HJ; Lee SG; Shim BS; Sethi G; Ahn KS
Apoptosis; 2014 Apr; 19(4):708-18. PubMed ID: 24370994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
